Company CVAbout Pfizer Ltd. 
Pfizer Ltd.
Small Cap
Pharmaceuticals & Biotechnology
Pfizer Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company offer a portfolio of 150 specialised medicines in 15 therapeutic areas across 4 business categories. It has its own manufacturing facility at Goa and Thane. It has the distinction of being the first pharmaceutical company in India to start clinical research. The Company sells products in nearly 185 countries having 43 manufacturing sites globally.
Company Coordinates
Company Details
The Capital 1802/1901 Plot-C70, G Bl Bandra Kurla Cpx Bandra-E Mumbai Maharashtra : 400051
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 45.75 Cr
Number of Shares
4.57 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
17-Dec-2014
4.57
45.75
15906292
10
Amalgamation
17-Dec-2014
4.57
45.75
15906292
10
Amalgamation
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 28 Schemes (11.74%)
FIIs
Held by 88 FIIs (2.6%)
Promoter with highest holding
Pfizer East India B V (39.75%)
Highest Public shareholder
Nippon Life India Trustee Ltd (4.17%)
Individual Investors Holdings
12.08%
Board of Directors
Management
Designation
Remuneration
Prajeet Nair
Company Sec. & Compli. Officer
0
Uday Khanna
Independent Director
24.0 lacs
Sunil Lalbhai
Independent Director
23.7 lacs
MILIND ANIL PATIL
Executive Director (Finance)
3.6 cr
MEENA GANESH
Independent Director
22.3 lacs
Samir Kazi
Executive Director
3.03 cr
Pradip P Shah
Chairman & Independent Directo
0
Meenakshi Nevatia
Managing Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical
1,119.08
53.76%
Traded Goods
911.41
43.79%
Sale of Services (Clinical Research & Support Services)
50.93
2.45%
Pharmaceutical
Pharmaceutical
Traded Goods
Traded Goods
Sale of Services (Clinical Research & Support Services)
Sale of Services (Clinical Research & Support Services)
Stock DNARevenue and Profits:
Net Sales:
642 Cr
(Quarterly Results - Sep 2025)
Net Profit:
189 Cr
Pharmaceuticals & Biotechnology
INR 22,869 Cr (Small Cap)
32.00
34
3.30%
-0.69
18.32%
5.94
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
